Myocarditis in COVID-19 presenting with cardiogenic shock: a case series

• Published in: European heart journal. Case reports 2021, Vol.5 (2), p.ytab028-ytab028
• Main Authors: Purdy, Adam, Ido, Firas, Sterner, Stacie, Tesoriero, Eric, Matthews, Tokunbo, Singh, Abhishek
• Format: Report
• Language: English
• ISSN: 2514-2119
• DOI: 10.1093/ehjcr/ytab028

BACKGROUNDSARS-CoV2, also known as COVID-19, is a specific strain of coronavirus that is responsible for an ongoing global pandemic. COVID-19 primarily targets the respiratory system via droplet transmission, causing symptoms similar to influenza, including fever, cough, and shortness of breath. It is now known to impact other organ systems, causing significant cardiovascular and gastrointestinal illness, among others. CASE SUMMARYWe describe two cases of COVID-19 induced myocarditis presenting with cardiogenic shock. These cases highlight the importance of understanding the lethal cardiac complications of COVID-19 infection, as well as its presentation, diagnosis, pathophysiology, and potential treatment options. These two cases involve patients without underlying cardiovascular disease risk factors who experienced prolonged symptoms of COVID-19 infection. Both patients presented with cardiogenic shock more than one week after symptom onset and diagnosis. These cases demonstrate the late presentation of myocarditis and cardiogenic shock, treated with corticosteroids and inotropes, with subsequent recovery of cardiac function. DISCUSSIONThe cases highlight the importance of recognizing late presentation viral myocarditis secondary to COVID-19 infection, even in patients without underlying cardiac disease.